DASA-58 - 98%, high purity , CAS No.1203494-49-8, Activator of pyruvate kinase M1/2

Item Number
D413874
Grouped product items
SKUSizeAvailabilityPrice Qty
D413874-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$319.90
D413874-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,198.90
D413874-50mg
50mg
In stock
$1,799.90
D413874-100mg
100mg
In stock
$3,041.90

PKM Activators

Basic Description

Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsDASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeACTIVATOR
Mechanism of actionActivator of pyruvate kinase M1/2
Product Description

Information

DASA-58 DASA-58 is a specific and potent Pyruvate kinase M2 (PKM2) activator.


Targets

PKM2


In vitro

DASA-58 inhibits LPS-induced Hif-1α and IL-1β, as well as the expression of a range of other Hif-1α-dependent genes in primary BMDMs, and also inhibits glycolysis and the accumulation of succinate in LPS-activated macrophages. In PC3 cells, DASA-58 impairs stromal-induced EMT program by restoring PK activity and abrogating the nuclear translocation of PKM2, as well as its association with HIF-1α. DASA-58 also dramatically reduces (~6-fold) CAFs-induced lung metastases formation in PC3 cells.


In vivo

DASA-58 (40 μM) affects EMT of prostate cancers and tumor dissemination in SCID mice.

Product Properties

ALogP0.632
HBD Count1
Rotatable Bond4

Associated Targets(Human)

PKM Tchem Pyruvate kinase PKM (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Associated Targets(non-human)

Pkm Pyruvate kinase isozymes M1/M2 (66 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pklr Pyruvate kinase isozymes R/L (113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name 3-[[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1,4-diazepan-1-yl]sulfonyl]aniline
INCHI InChI=1S/C19H23N3O6S2/c20-15-3-1-4-16(13-15)29(23,24)21-7-2-8-22(10-9-21)30(25,26)17-5-6-18-19(14-17)28-12-11-27-18/h1,3-6,13-14H,2,7-12,20H2
InChi Key GMHIOMMKSMSRLY-UHFFFAOYSA-N
Canonical SMILES C1CN(CCN(C1)S(=O)(=O)C2=CC=CC(=C2)N)S(=O)(=O)C3=CC4=C(C=C3)OCCO4
Isomeric SMILES C1CN(CCN(C1)S(=O)(=O)C2=CC=CC(=C2)N)S(=O)(=O)C3=CC4=C(C=C3)OCCO4
PubChem CID 44543605
Molecular Weight 453.53

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot NumberCertificate TypeDateItem
G2221185Certificate of AnalysisJun 11, 2022 D413874
G2221205Certificate of AnalysisJun 11, 2022 D413874

Chemical and Physical Properties

SolubilitySolubility (25°C) In vitro DMSO: 91 mg/mL (200.64 mM); Water: Insoluble; Ethanol: Insoluble;
DMSO(mg / mL) Max Solubility91
DMSO(mM) Max Solubility200.6482482
Water(mg / mL) Max Solubility<1

Related Documents

References

1. Walsh MJ, Brimacombe KR, Veith H, Bougie JM, Daniel T, Leister W, Cantley LC, Israelsen WJ, Vander Heiden MG, Shen M et al..  (2011)  2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase..  Bioorg Med Chem Lett,  21  (21): (6322-7).  [PMID:21958545] [10.1021/op500134e]
2. Anastasiou D, Yu Y, Israelsen WJ, Jiang JK, Boxer MB, Hong BS, Tempel W, Dimov S, Shen M, Jha A et al..  (2012)  Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis..  Nat Chem Biol,  (10): (839-47).  [PMID:22922757] [10.1021/op500134e]

Solution Calculators